Catalyst Wire Dossier Catalyst Wire Dossier

AP214

AP214 · Action Pharma A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP214, covering 2012-03-15 to 2012-03-15. Get the full timeline:

Most recent: Clinical Trial Update: An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery [Phase 2]

See pricing